Literature DB >> 25044503

A genome-wide linkage scan of bipolar disorder in Latino families identifies susceptibility loci at 8q24 and 14q32.

Suzanne Gonzalez1, Cynthia Camarillo, Marco Rodriguez, Mercedes Ramirez, Juan Zavala, Regina Armas, Salvador A Contreras, Javier Contreras, Albana Dassori, Laura Almasy, Deborah Flores, Alvaro Jerez, Henriette Raventós, Alfonso Ontiveros, Humberto Nicolini, Michael Escamilla.   

Abstract

A genome-wide nonparametric linkage screen was performed to localize Bipolar Disorder (BP) susceptibility loci in a sample of 3757 individuals of Latino ancestry. The sample included 963 individuals with BP phenotype (704 relative pairs) from 686 families recruited from the US, Mexico, Costa Rica, and Guatemala. Non-parametric analyses were performed over a 5 cM grid with an average genetic coverage of 0.67 cM. Multipoint analyses were conducted across the genome using non-parametric Kong & Cox LOD scores along with Sall statistics for all relative pairs. Suggestive and significant genome-wide thresholds were calculated based on 1000 simulations. Single-marker association tests in the presence of linkage were performed assuming a multiplicative model with a population prevalence of 2%. We identified two genome-wide significant susceptibly loci for BP at 8q24 and 14q32, and a third suggestive locus at 2q13-q14. Within these three linkage regions, the top associated single marker (rs1847694, P = 2.40 × 10(-5)) is located 195 Kb upstream of DPP10 in Chromosome 2. DPP10 is prominently expressed in brain neuronal populations, where it has been shown to bind and regulate Kv4-mediated A-type potassium channels. Taken together, these results provide additional evidence that 8q24, 14q32, and 2q13-q14 are susceptibly loci for BP and these regions may be involved in the pathogenesis of BP in the Latino population.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Central-American; Mexican; Mexican-American; bipolar disorder; family studies; genetics

Mesh:

Year:  2014        PMID: 25044503     DOI: 10.1002/ajmg.b.32251

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  5 in total

1.  Neuropsychiatric genetics in developing countries: Current challenges.

Authors:  Diego A Forero; Alberto Vélez-van-Meerbeke; Smita N Deshpande; Humberto Nicolini; George Perry
Journal:  World J Psychiatry       Date:  2014-12-22

2.  Identification of rare nonsynonymous variants in SYNE1/CPG2 in bipolar affective disorder.

Authors:  Sally Isabel Sharp; Jenny Lange; Radhika Kandaswamy; Mazen Daher; Adebayo Anjorin; Nicholas James Bass; Andrew McQuillin
Journal:  Psychiatr Genet       Date:  2017-06       Impact factor: 2.458

3.  Neuropsychiatric Genetics of Psychosis in the Mexican Population: A Genome-Wide Association Study Protocol for Schizophrenia, Schizoaffective, and Bipolar Disorder Patients and Controls.

Authors:  Beatriz Camarena; Elizabeth G Atkinson; Mark Baker; Claudia Becerra-Palars; Lori B Chibnik; Raúl Escamilla-Orozco; Joanna Jiménez-Pavón; Zan Koenig; Carla Márquez-Luna; Alicia R Martin; Ingrid Pamela Morales-Cedillo; Ana Maria Olivares; Hiram Ortega-Ortiz; Alejandra Monserrat Rodriguez-Ramírez; Ricardo Saracco-Alvarez; Rebecca E Basaldua; Brena F Sena; Karestan C Koenen
Journal:  Complex Psychiatry       Date:  2021-08-24

4.  A genome-wide quantitative trait locus (QTL) linkage scan of NEO personality factors in Latino families segregating bipolar disorder.

Authors:  Byung Dae Lee; Suzanne Gonzalez; Erika Villa; Cynthia Camarillo; Marco Rodriguez; Yin Yao; Wei Guo; Deborah Flores; Alvaro Jerez; Henriette Raventos; Alfonso Ontiveros; Humberto Nicolini; Michael Escamilla
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-05-29       Impact factor: 3.358

5.  A genome-wide screen for acrophobia susceptibility loci in a Finnish isolate.

Authors:  Zuzanna Misiewicz; Tero Hiekkalinna; Tiina Paunio; Teppo Varilo; Joseph D Terwilliger; Timo Partonen; Iiris Hovatta
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.